BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25062648)

  • 1. The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients.
    Bernat-García J; Morales Suárez-Varela M; Vilata-Corell JJ; Marquina-Vila A; Pallardo L; Crespo J
    Actas Dermosifiliogr; 2014 Dec; 105(10):940-6. PubMed ID: 25062648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
    Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
    J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
    Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
    Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
    Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
    Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy in the posttransplant period and skin cancer.
    Krásová M; Sečníková Z; Göpfertová D; Hercogová J; Viklický O; Jůzlová K; Jiráková A; Šmerhovský Z
    Dermatol Ther; 2016 Nov; 29(6):433-436. PubMed ID: 27328964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical insights for cancer outcomes in renal transplant patients.
    Alberú J
    Transplant Proc; 2010 Nov; 42(9 Suppl):S36-40. PubMed ID: 21095450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periocular Skin Cancer in Solid Organ Transplant Recipients.
    Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
    Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
    Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
    Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients.
    Burke MT; Morais C; Oliver KA; Lambie DL; Gobe GC; Carroll RP; Staatz CE; Sinnya S; Soyer HP; Winterford C; Haass NK; Campbell SB; Isbel NM
    Am J Clin Pathol; 2015 Apr; 143(4):514-26. PubMed ID: 25780003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
    Eckembrecher DG; Eckembrecher FJ; Camacho I; Shah H; Dave Y; Patel S; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2491-2503. PubMed ID: 37256379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.